News | October 30, 2022
Kopran acquire assets of Abhinandan Rasayan
Once the unit is made fully functional, it will help the company in increasing its API and intermediate production capacity
Once the unit is made fully functional, it will help the company in increasing its API and intermediate production capacity
The observation is procedural in nature and the company will address the observation within stipulated timelines.
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
The company has posted net profit of Rs. 13.21 crores for the period ended September 30, 2022
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
The JUMP-CP Consortium’s aim is to validate and scale up image-based drug discovery strategies by creating the world’s largest public cell imaging data set
Oncodesign Services (ODS ), with 600 clients in 33 countries and 227 employees worldwide, provides services from target identification to hit-to-lead and lead optimization through to IND filing.
Gland Pharma Q2 FY2023 consolidated net profit up at Rs. 241.24 Cr
The company has reported total income of Rs. 3109.77 crores during the period ended September 30, 2022
Subscribe To Our Newsletter & Stay Updated
